Benefits at 5 years of routine invasive strategy in Non-ST-Elevation Acute Coronary Syndromes

Original title: Impact of an invasive strategy on five years outcomein men and women with Non-ST-Elevation Acute Coronary Syndromes. Reference: Joakim Alfredsson et al. Am Heart J. 2014;Epub ahead of print.

 

This meta-analysis included patients with non-ST-elevation acute coronary syndrome (NSTE ACS) from randomized studies FRISC II, ICTUS and RITA 3 and compared the routine invasive strategy (n=2721) with coronary catheterization and, when possible, angioplasty or surgery vs. a more selective strategy (n=2746) consisting of initial stabilization with medical therapy, leaving coronary catheterization for patients with recurrent ischemia symptoms despite medical treatment, hemodynamically unstable, or showing signs of ischemia on a stress test. 

Women represented one third of overall cohort (n=1751), were of older age, smoked less and had higher hypertension rates than men. On the other hand, men often had a history of MI and revascularization.

After a 5 year follow up, routine invasive strategy in men reduced primary end point of cardiovascular death or AMI (15.6% vs 19.8%; p=0.01), and individual components, cardiovascular death (6.6% vs 8,7%; p=0.07) and AMI (10.8% vs 14.6%; p=0.01). These same points saw no significant change in women.

In the light of a risk stratified analysis, men presenting medium or high risk non ST elevation AMI at baseline, saw benefit from the routine invasive strategy. On the contrary, women in all risk subgroups saw a similar prognosis, regardless of treatment strategy. 

Conclusion

This meta-analysis based in three large randomized studies on non ST elevation AMI confirmed the long term benefit of routine invasive strategy in men, while women saw no significant benefit.

Editorial Comment

Subgroup analysis, especially if not pre specified by protocol, must be interpreted with caution. Even in this large dataset, the number of events in women was low and the difference between men and women could be the result of weak statistical power in women.

Among randomized patients undergoing routine invasive strategy, women often lack significant lesions (28.2% vs 9.3%) and are less likely to have 3 vessel lesions (21.1% vs 30.6%). 

To conclude, women had less severe coronary disease and this may have reduced the benefit of a routine invasive strategy. Today, guidelines have no specific recommendation as regards gender for non ST elevation AMI syndromes. 

SOLACI.ORG

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...